0
Department of Veterans Affairs Awarded a Contract to PROGENICS PHARMACEUTICALS INC for $332,280.71
Signed on
7/6/2022, 12:00 AM
PROGENICS PHARMACEUTICALS INC Government Contract #36C26022F0369
PROGENICS PHARMACEUTICALS INC was awarded a contract with the United States Government for $332,280.71. The contract was awarded by the agency office 260-NETWORK CONTRACT OFFICE 20 (36C260), which is a division with the Department of Veterans Affairs within the Department of Veterans Affairs.
Summary of Award
The recipient of the federal contract is Progenics Pharmaceuticals Inc, a U.S.-owned business that operates in the pharmaceutical industry. The contract, funded by the Department of Veterans Affairs, is for the drug Pylarify (Piflufolastat F18) and is worth $332,280.71. Notable transactions include amounts of $3608.72, -$83,291.91, $166,014, and $245,949.90 related to the contract.
Contract Details
Agency Details
Recipient Details
Comments
Award Transactions
Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $3,608.72 to PROGENICS PHARMACEUTICALS INC. The payment included a Subsidy Cost of $0.00.
Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $-83,291.91 to PROGENICS PHARMACEUTICALS INC. The payment included a Subsidy Cost of $0.00.
This payment could indicate a change to the existing contract.
Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $166,014.00 to PROGENICS PHARMACEUTICALS INC. The payment included a Subsidy Cost of $0.00.
Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $245,949.90 to PROGENICS PHARMACEUTICALS INC. The payment included a Subsidy Cost of $0.00.